(Circulation. 2000;101:1982.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Nitric Oxide Modulates Expression of Cell Cycle Regulatory Proteins
A Cytostatic Strategy for Inhibition of Human Vascular Smooth Muscle Cell Proliferation
From the Cardiovascular Research (F.C.T., H.G., T.F.L.), Physiology Institute, University Zürich-Irchel; Division of Cardiology (F.C.T., T.F.L.), University Hospital, Zürich, Switzerland; Ophthalmology University Hospital (P.M., C.C.), Basel, Switzerland; and Division of Cardiology (E.G.N.), University of Michigan Medical Center, Ann Arbor, Mich.
Correspondence to Thomas F. Lüscher, MD, Cardiology, University Hospital, Rämistrasse 100, 8091 Zürich, Switzerland.
Background—We examined the effect of NO on the proliferation and cell cycle regulation of human aortic vascular smooth muscle cells (VSMCs).
Methods and Results—The NO donor diethylenetriamineNONOate (10-5 to 10-3 mol/L) inhibited proliferation in response to 10% fetal calf serum (FCS) and 100 ng/mL platelet-derived growth factor-BB in a concentration-dependent manner. This effect was not observed with disintegrated diethylenetriamineNONOate or with the parent compound, diethylenetriamine. Adenoviral transfection of endothelial NO synthase (NOS) inhibited proliferation in response to FCS, which was prevented with NG-nitro-L-arginine methyl ester. NOS overexpression did not inhibit proliferation in response to platelet-derived growth factor, although the transfection efficiency and protein expression were similar to those of FCS-stimulated cells. Nitrate release was selectively enhanced from FCS-treated cells, indicating that NOS was activated by FCS only. NO caused G1 cell cycle arrest. Cytotoxicity was determined with trypan blue exclusion, and apoptosis was assessed with DNA fragmentation. Cyclin-dependent kinase 2 expression level, threonine phosphorylation, and kinase activity were inhibited. Cyclin A expression was blunted, whereas cyclin E remained unchanged. p21 expression was induced, and p27 remained unaltered. The effect on cyclin A and p21 started within 6 hours and preceded the changes in cell cycle distribution. Proliferation in response to 10% FCS was barely inhibited with 8-bromo-cGMP (10-3 mol/L) but was blunted with both forskolin and 8-bromo-cAMP. Proliferation in response to 2% FCS was inhibited with 8-bromo-cGMP, but it did not mimic the cell cycle effects of NO.
Conclusions—NO inhibits VSMC proliferation by specifically changing the expression and activity of cell cycle regulatory proteins, which may occur independent of cGMP. Adenoviral overexpression of endothelial NOS represents a cytostatic strategy for gene therapy of vascular disease.
Key Words: endothelium-derived factors • nitric oxide • nitric oxide synthase • platelet-derived factors • gene therapy
This article has been cited by other articles:
 |
|
 |
|
  M. T. Kearney, E. R. Duncan, M. Kahn, and S. B. Wheatcroft Insulin resistance and endothelial cell dysfunction: studies in mammalian models Exp Physiol, January 1, 2008; 93(1): 158 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nakaya, J. Hemish, P. Krasnov, S.-Y. Kim, Y. Stasiv, T. Michurina, D. Herman, M. S. Davidoff, R. Middendorff, and G. Enikolopov noxin, a Novel Stress-Induced Gene Involved in Cell Cycle and Apoptosis Mol. Cell. Biol., August 1, 2007; 27(15): 5430 - 5444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Carreras and J. J. Poderoso Mitochondrial nitric oxide in the signaling of cell integrated responses Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1569 - C1580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Camici, J. Steffel, A. Akhmedov, N. Schafer, J. Baldinger, U. Schulz, K. Shojaati, C. M. Matter, Z. Yang, T. F. Luscher, et al. Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents Circulation, October 3, 2006; 114(14): 1512 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Milliat, A. Francois, M. Isoir, E. Deutsch, R. Tamarat, G. Tarlet, A. Atfi, P. Validire, J. Bourhis, J.-C. Sabourin, et al. Influence of Endothelial Cells on Vascular Smooth Muscle Cells Phenotype after Irradiation: Implication in Radiation-Induced Vascular Damages Am. J. Pathol., October 1, 2006; 169(4): 1484 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cordelier, J.-P. Esteve, S. Najib, L. Moroder, N. Vaysse, L. Pradayrol, C. Susini, and L. Buscail Regulation of Neuronal Nitric-oxide Synthase Activity by Somatostatin Analogs following SST5 Somatostatin Receptor Activation J. Biol. Chem., July 14, 2006; 281(28): 19156 - 19171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-J. Wu, M. Bond, G. B. Sala-Newby, and A. C. Newby Altered S-Phase Kinase-Associated Protein-2 Levels Are a Major Mediator of Cyclic Nucleotide-Induced Inhibition of Vascular Smooth Muscle Cell Proliferation Circ. Res., May 12, 2006; 98(9): 1141 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Stahli, H. Greutert, S. Mei, P. Graf, K. Frischknecht, M. Stalder, L. Englberger, A. Kunzli, L. Scharer, T. F. Luscher, et al. Absence of histamine-induced nitric oxide release in the human radial artery: implications for vasospasm of coronary artery bypass vessels Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1182 - H1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Noronha, J.-M. Li, S. B. Wheatcroft, A. M. Shah, and M. T. Kearney Inducible Nitric Oxide Synthase Has Divergent Effects on Vascular and Metabolic Function in Obesity Diabetes, April 1, 2005; 54(4): 1082 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mizuno, M. Kadowaki, Y. Demura, S. Ameshima, I. Miyamori, and T. Ishizaki p42/44 Mitogen-Activated Protein Kinase Regulated by p53 and Nitric Oxide in Human Pulmonary Arterial Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 184 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Shi, R. L. Stewart Jr, E. Perez, J. Y.-H. Chen, and P. S. LaPolt Cell-Specific Expression and Regulation of Soluble Guanylyl Cyclase {alpha}1 and {beta}1 Subunits in the Rat Ovary Biol Reprod, June 1, 2004; 70(6): 1552 - 1561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kong, L. G. Melo, A. A. Mangi, L. Zhang, M. Lopez-Ilasaca, M. A. Perrella, C. C. Liew, R. E. Pratt, and V. J. Dzau Enhanced Inhibition of Neointimal Hyperplasia by Genetically Engineered Endothelial Progenitor Cells Circulation, April 13, 2004; 109(14): 1769 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Tanner, T. Largiader, H. Greutert, Z. Yang, and T. F. Luscher Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 20 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.P. Mason, P. Marche, and T.H. Hintze Novel Vascular Biology of Third-Generation L-Type Calcium Channel Antagonists: Ancillary Actions of Amlodipine Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2155 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pignatti and C. Stefanelli Ischemia/reperfusion-induced apoptosis: connecting nitric oxide and cell cycle regulators Cardiovasc Res, August 1, 2003; 59(2): 268 - 270. [Full Text] [PDF]
|
|
|
|
|
|
Y. Maejima, S. Adachi, H. Ito, K. Nobori, M. Tamamori-Adachi, and M. Isobe Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity Cardiovasc Res, August 1, 2003; 59(2): 308 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Tanner, H. Greutert, C. Barandier, K. Frischknecht, and T. F. Luscher Different Cell Cycle Regulation of Vascular Smooth Muscle in Genetic Hypertension Hypertension, August 1, 2003; 42(2): 184 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Komers and S. Anderson Paradoxes of nitric oxide in the diabetic kidney Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1121 - F1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Viani, P. Giussani, L. Brioschi, R. Bassi, V. Anelli, G. Tettamanti, and L. Riboni Ceramide in Nitric Oxide Inhibition of Glioma Cell Growth. EVIDENCE FOR THE INVOLVEMENT OF CERAMIDE TRAFFIC J. Biol. Chem., March 7, 2003; 278(11): 9592 - 9601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wessely, L. Hengst, B. Jaschke, F. Wegener, T. Richter, R. Lupetti, M. Paschalidis, A. Schomig, R. Brandl, and F.-J. Neumann A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia Hum. Mol. Genet., January 15, 2003; 12(2): 177 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tateshima, Y. Murayama, J. P. Villablanca, T. Morino, K. Nomura, K. Tanishita, and F. Vinuela In Vitro Measurement of Fluid-Induced Wall Shear Stress in Unruptured Cerebral Aneurysms Harboring Blebs Stroke, January 1, 2003; 34(1): 187 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. D'Souza, R. L. Sparks, H. Chen, P. J. Kadowitz, and J. R. Jeter Jr. Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation Am J Physiol Cell Physiol, January 1, 2003; 284(1): C191 - C199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakamura, Y. Yamagata, N. Sugino, H. Takayama, and H. Kato Nitric Oxide Inhibits Oocyte Meiotic Maturation Biol Reprod, November 1, 2002; 67(5): 1588 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Shuhaiber, A. N. Evans, M. G. Massad, and A. S. Geha Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery Eur. J. Cardiothorac. Surg., September 1, 2002; 22(3): 387 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T Gewaltig and G. Kojda Vasoprotection by nitric oxide: mechanisms and therapeutic potential Cardiovasc Res, August 1, 2002; 55(2): 250 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hurlimann, F. Ruschitzka, and T.F. Luscher The relationship between the endothelium and the vessel wall Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A1 - A7. [Abstract] [PDF]
|
|
|
|
|
|
S. Krick, O. Platoshyn, M. Sweeney, S. S. McDaniel, S. Zhang, L. J. Rubin, and J. X.-J. Yuan Nitric oxide induces apoptosis by activating K+ channels in pulmonary vascular smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H184 - H193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M.A.B. Van Bortel, H. A.J. Struijker-Boudier, and M. E. Safar Pulse Pressure, Arterial Stiffness, and Drug Treatment of Hypertension Hypertension, October 1, 2001; 38(4): 914 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Lincoln, N. Dey, and H. Sellak Signal Transduction in Smooth Muscle: Invited Review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression J Appl Physiol, September 1, 2001; 91(3): 1421 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Tuttle, R. D. Nachreiner, A. S. Bhuller, K. W. Condict, B. A. Connors, B. P. Herring, M. C. Dalsing, and J. L. Unthank Shear level influences resistance artery remodeling: wall dimensions, cell density, and eNOS expression Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1380 - H1389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Holt eNOS inhibition of proliferation: a role for p21Sdi1/Cip1/Waf1 and p27kip1 Cardiovasc Res, September 1, 2000; 47(4): 640 - 641. [Full Text] [PDF]
|
|